Adam Cherry, PA
Physician Assistant · Longview, WANPI 1770805673
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Biocryst US Sales Co., LLC at 26.2% of the total. Among physician assistant clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 359 payments — averaging $42.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biocryst US Sales Co., LLC$4K
- Biocryst Pharmaceuticals, Inc.$3K
- GSK$1K
- AstraZeneca$1K
- CSL Behring$834
- Regeneron Healthcare Solutions, Inc.$797
- plus $4K from 25 others
What the payments were for
- Consulting fees$5,63037%
- Speaking & faculty fees$7505%
- Travel & lodging$1,3389%
- Food & beverage$7,33749%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biocryst US Sales Co., LLC | 12 | $3,960 |
| Biocryst Pharmaceuticals, Inc. | 3 | $2,766 |
| GSK | 52 | $1,427 |
| AstraZeneca | 59 | $1,425 |
| CSL Behring | 63 | $834 |
| Regeneron Healthcare Solutions, Inc. | 17 | $797 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $628 |
| Amgen | 17 | $382 |
| Novartis | 15 | $349 |
| Kaleo, Inc. | 10 | $266 |
| Octapharma USA, Inc. | 4 | $235 |
| Grifols USA, LLC | 14 | $227 |
| Blueprint Medicines Corporation | 5 | $213 |
| Genentech USA, Inc. | 9 | $197 |
| Pharming Healthcare, Inc. | 9 | $193 |
| Boehringer Ingelheim | 6 | $177 |
| Pfizer | 6 | $160 |
| AbbVie | 4 | $153 |
| Alk-abello, Inc | 2 | $145 |
| Lilly USA, LLC | 3 | $132 |
| Sanofi | 5 | $107 |
| Tersera Therapeutics LLC | 2 | $64 |
| Phathom Pharmaceuticals, Inc. | 2 | $61 |
| Verona Pharma, Inc. | 2 | $50 |
| Bio Products Laboratory USA, Inc. | 2 | $31 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| Organon | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| ADMA Biomanufacturing LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,102 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $2,693 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $445 |
| Hydroxyzine Hcl | 16 | $404 |
| Prednisone | 12 | $43 |
| Montelukast Sodium | 13 | $42 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Longview
- Rachel RoylanceLongview$11K
- Nicholas AustinLongview$8K
- Jill KandoraShoreline$437K
- Jeannette HartRichland$263K
- Lance KeckTacoma$162K
- Erinn KingSeattle$129K
- Christy VathSeattle$75K
- Scott TaylorMercer Island$71K
- Gina FragioneGraham$69K
- Regan BrownSpokane$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.